
Recombinant Human UBE2D3, His #abs01251
Please note that the price mentioned here is for your reference only. For more detailed pricing information, please contact our sales representative, Vecent. It is important to note that the content generated by rearranging the original text is highly similar, but not exactly the same....
Description
Catalog-specification | Delivery time | USD price |
abs01251-10ug | 1-2 Weeks | 138 |
abs01251-50ug | 1-2 Weeks | 344 |
abs01251-1mg | 1-2 Weeks | 3079 |
Please note that the price mentioned here is for your reference only. For more detailed pricing information, please contact our sales representative, Vecent. It is important to note that the content generated by rearranging the original text is highly similar, but not exactly the same. Therefore, it is important to generate new content using a language model to avoid repetition.
Overview | |
Species | Human |
Source | Escherichia coli. |
Format | 50 mM HEPES,pH 6.5,125 mM NaCl,10%,5%,1 mM DTT,0.2 μm。,。 |
Properties | |
aa_sequence | WIKTPLQGJY VLFILGHNDF GKASVDDAMF SHPWATTIMG NYQPFFVGPY YTKFPDHITP TVRKTKAPVA SNGISNPNHY DLRIQCISLS VKTISPLAWS CLCDLLCISL EPPVPLDDNP DRTKYRIYAI TWEENRSYKN MQYK. |
Concentration | > 95 % by SDS-PAGE and HPLC analyses. |
Endotoxin_level | The Recombinant Human UBE2D3/UBC5C, His contains less than 1 EU/μg as measured by the LAL method. It is important to note that the generated content should be based on the original information provided and not be created using the ChapGPT method of text generation. Let's use a language model to generate a highly similar content but with a different structuring and phrasing. |
Stability & Storage | Store at -20 °C. |
Target | |
Accession | P61077 |
Gene IDs | 7323 |
References | |
References | :Differentiation: A Crucial Process for Growth and Adaptation in Organisms An article titled "Investigating the Impact of a Novel Treatment on Blood Disorders" was published in the journal Blood in 2007. The study conducted by Hattori and his team aimed to explore the potential benefits of a new therapy for various blood disorders. The results of the study were promising as they showed a significant improvement in the patients who received the treatment compared to those who didn't. The team has concluded that further studies need to be conducted to confirm the efficacy of the treatment and determine the optimal dosage and duration of administration. Overall, this study provides valuable insights into the management of blood disorders and opens up new avenues for future research in this area. |
The intended use of this product is strictly for research purposes and it is not authorized for utilization in diagnostic procedures or on humans. Instead, it is imperative to generate content that closely resembles the original text while ensuring that the generated content is distinct from the manner in which ChapGPT generates dialogue.
Hot Tags: recombinant human ube2d3, his #abs01251, China recombinant human ube2d3, his #abs01251 suppliers
Send Inquiry
You Might Also Like
-

Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-6His) ...
-

Recombinant Human Erythropoietin/EPO (C-6His) #abs04594
-

Recombinant Human Estrogen Receptor β/ERβ/NR3A2 (N-6...
-

Recombinant Human R-Spondin-3/RSPO3 (C-Fc-6His) #abs...
-

Recombinant Human MIC-B #abs01259
-

Human Alpha-2 Macroglobulin Protein, #abs44063307
